TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN-Reference-Cited by-同舟云学术

TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN

Author:

Inglefield Jon R.¹²,Dumitru Calin Dan¹³,Alkan Sefik S.¹⁴,Gibson Sheila J.¹,Lipson Kenneth E.¹⁵,Tomai Mark A.¹,Larson Chris J.¹⁶,Vasilakos John P.¹⁷

Affiliation:

1. 3M Company, St. Paul, MN 55144.

2. Current address: MesoScale Discovery, Gaithersburg, MD 20877.

3. Current address: Genentech Inc., South San Francisco, CA 94080.

4. Current address: Alba Therapeutics Corp., Baltimore, MD 21201.

5. Current address: Fibrogen Inc., South San Francisco, CA 94080.

6. Current address: R&D Systems, Minneapolis, MN 55413.

7. Current address: Biothera, Eagan, MN 55121.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

Reference53 articles.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献